Alex Sanchez
Overview
Explore the profile of Alex Sanchez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1070
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Simats A, Ramiro L, Garcia-Berrocoso T, Brianso F, Gonzalo R, Martin L, et al.
Mol Cell Proteomics
. 2020 Sep;
19(12):1921-1936.
PMID: 32868372
Stroke remains a leading cause of death and disability worldwide. Despite continuous advances, the identification of key molecular signatures in the hyper-acute phase of ischemic stroke is still a primary...
12.
Matute-Blanch C, Calvo-Barreiro L, Carballo-Carbajal I, Gonzalo R, Sanchez A, Vila M, et al.
Sci Rep
. 2020 Apr;
10(1):7118.
PMID: 32346016
Chitinase 3-like 1 (CHI3L1) is known to play a role as prognostic biomarker in the early stages of multiple sclerosis (MS), and patients with high cerebrospinal fluid CHI3L1 levels have...
13.
Malhotra S, Costa C, Eixarch H, Keller C, Amman L, Martinez-Banaclocha H, et al.
Brain
. 2020 Apr;
143(5):1414-1430.
PMID: 32282893
Primary progressive multiple sclerosis is a poorly understood disease entity with no specific prognostic biomarkers and scarce therapeutic options. We aimed to identify disease activity biomarkers in multiple sclerosis by...
14.
DiNatale R, Gorelick A, Makarov V, Blum K, Silagy A, Freeman B, et al.
Eur Urol Focus
. 2019 Dec;
7(2):381-389.
PMID: 31813809
Background: TCEB1-mutant renal cell carcinoma (RCC) is a rare variant of RCC with clear-cell features. Owing to its unique morphological and molecular features it has recently been proposed as a...
15.
Malhotra S, Villar L, Costa C, Midaglia L, Cubedo M, Medina S, et al.
J Neuroinflammation
. 2018 Oct;
15(1):296.
PMID: 30367633
Background: Recent studies in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis (MS), suggest an involvement of the histone methyltransferase enhancer of zeste 2 polycomb repressive complex 2 subunit...
16.
Rodriguez-Fernandez S, Pujol-Autonell I, Brianso F, Perna-Barrull D, Cano-Sarabia M, Garcia-Jimeno S, et al.
Front Immunol
. 2018 Mar;
9:253.
PMID: 29491866
Type 1 diabetes (T1D) is a metabolic disease caused by the autoimmune destruction of insulin-producing β-cells. With its incidence increasing worldwide, to find a safe approach to permanently cease autoimmunity...
17.
Matute-Blanch C, Villar L, Alvarez-Cermeno J, Rejdak K, Evdoshenko E, Makshakov G, et al.
Brain
. 2018 Feb;
141(4):1085-1093.
PMID: 29452342
The prognostic role of cerebrospinal fluid molecular biomarkers determined in early pathogenic stages of multiple sclerosis has yet to be defined. In the present study, we aimed to investigate the...
18.
Almanza-Aguilera E, Urpi-Sarda M, Llorach R, Vazquez-Fresno R, Garcia-Aloy M, Carmona F, et al.
J Nutr Biochem
. 2017 Jul;
48:36-43.
PMID: 28692847
The study of biomarkers of dietary patterns including the Mediterranean diet (MedDiet) is scarce and could improve the assessment of these patterns. Moreover, it could provide a better understanding of...
19.
Fissolo N, Pignolet B, Matute-Blanch C, Trivino J, Miro B, Mota M, et al.
Ann Neurol
. 2017 Jul;
82(2):186-195.
PMID: 28681388
Objective: To identify biomarkers associated with the development of progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS) patients treated with natalizumab (NTZ). Methods: Relapsing-remitting MS patients who developed PML under...
20.
Navarro A, Clot G, Martinez-Trillos A, Pinyol M, Jares P, Gonzalez-Farre B, et al.
Haematologica
. 2017 May;
102(9):e360-e363.
PMID: 28522579
No abstract available.